During the past decade, Mbeya Med. Research Program, Mbeya Referral Hosp. CRS conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mbeya Med. Research Program, Mbeya Referral Hosp. CRS" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 18 trials, followed by "Michael Hoelscher" with 6 trials sponsored, "Foundation for Innovative New Diagnostics, Switzerland" with 2 trials sponsored, "Global Alliance for TB Drug Development" with 2 trials sponsored and "The Aurum Institute NPC" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mbeya Med. Research Program, Mbeya Referral Hosp. CRS" #1 collaborator was "National Institute for Medical Research, Tanzania" with 7 trials as a collaborator, "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 6 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 5 trials as a collaborator, "Instituto Nacional de Saúde, Mozambique" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "Mbeya Med. Research Program, Mbeya Referral Hosp. CRS" are "HIV Infections" (18 trials), "Tuberculosis" (5 trials), "Pulmonary Tuberculosis" (4 trials), "Tuberculosis, Pulmonary" (4 trials) and "Diagnoses Disease" (3 trials). Many other conditions were trialed in "Mbeya Med. Research Program, Mbeya Referral Hosp. CRS" in a lesser frequency.

Most popular intervention types in "Mbeya Med. Research Program, Mbeya Referral Hosp. CRS" are "Drug" (20 trials), "Biological" (7 trials), "Diagnostic Test" (4 trials), "Other" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (4 trials), "Didanosine" (3 trials), "Placebo" (3 trials), "Bedaquiline, Delamanid, Moxifloxacin" (2 trials) and "Clarithromycin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mbeya Med. Research Program, Mbeya Referral Hosp. CRS" are 33 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Mbeya Med. Research Program, Mbeya Referral Hosp. CRS". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Mbeya Med. Research Program, Mbeya Referral Hosp. CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mbeya Med. Research Program, Mbeya Referral Hosp. CRS, 4 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".